Actualités - Page 4 sur 4 - Laborie

Obstétrique, gynécologie et néonatale

Laborie Medical Technologies to Invest in Medical Technology Start-Up Novocuff

Laborie announced its investment in Novocuff, an early-stage medical technology company headquartered in Mountain View, CA.

Gastroentérologie

Laborie Introduces Solar Compact System and Solar Anorectal Manometry Catheter for Enhanced Gastrointestinal Diagnostics

Laborie is proud to introduce the Solar Compact System and Solar Anorectal Manometry Catheter, the first disposable HRAM catheter on the market.

Urologie et urogynécologie

Laborie Unveils Positive Study Results for Optilume® BPH Catheter System

Laborie announced positive 2-year and 5-year results from studies for its Optilume® BPH Catheter System.

Urologie et urogynécologie

NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme

Laborie welcomed the inclusion of Optilume® Urethral Drug-Coated Balloon (DCB) into the National Health Service (NHS) Specialized Services Device Programme (SSDP) as of April 1, 2024.

Urologie et urogynécologie

Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device

Laborie Medical Technologies  announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA.

a laborie device with a hose attached to it

Gastroentérologie

Laborie Introduces the Next Generation RenovaRP™Centesis System

Announcing the launch of the RenovaRP™ Centesis System, an innovative fluid drainage device designed to advance patient care and improve efficiency for healthcare professionals.

laborie for dignity for life and brighturo a brighter future

Non classifié(e)

Laborie Medical Technologies Invests in Medical Technology Start-Up Bright Uro

Laborie Medical Technologies  announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA.

Non classifié(e) |

Urologie et urogynécologie

Laborie Medical Technologies Acquires Urotronic

Urotronic joins Laborie as part of a long-term growth strategy for the Portsmouth-based medical device company. Urotronic’s Optilume® BPH Catheter System, a unique minimally invasive surgical therapy (MIST), is a paradigm shift for patients and clinicians in global interventional urology.

Non classifié(e) |

Urologie et urogynécologie

Laborie Medical Technologies Announces Agreement to Acquire Urotronic for up to $600 Million

Acquisition expands urology portfolio and demonstrates Laborie’s commitment to providing proven, innovative solutions to physicians and patients globally

Non classifié(e)

Laborie Transitions Urology and Gastroenterology Sales Model in Australia

Page 4 sur 4«1 2 34